• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎干扰素α治疗期间发生的葡萄膜炎-小柳-原田病。

Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.

作者信息

Kasahara Akinori, Hiraide Atsushi, Tomita Naruya, Iwahashi Hiromi, Imagawa Akihisa, Ohguro Nobuyuki, Yamamoto Shuji, Mita Eiji, Hayashi Norio

机构信息

Department of General Medicine, Osaka University Graduate School of Medicine, 2-15 Yamada-Oka, 565-0871, Suita, Japan.

出版信息

J Gastroenterol. 2004 Nov;39(11):1106-9. doi: 10.1007/s00535-004-1452-4.

DOI:10.1007/s00535-004-1452-4
PMID:15580406
Abstract

Retinal abnormalities, including retinal hemorrhage and "cotton-wool" spots, often occur within the first 8 weeks in the course of interferon therapy in patients with chronic hepatitis C. Here, we describe a case of Vogt-Koyanagi-Harada disease occurring 4 months after the start of interferon alpha treatment, probably induced by the immunomodulatory effects of interferon. Therefore, we conclude that chronic hepatitis C patients, especially people with darkly pigmented skin, need to be closely monitored for ophthalmologic complications, by periodic check-up of the optic fundi, for a prolonged period, during interferon treatment.

摘要

视网膜异常,包括视网膜出血和“棉絮斑”,常出现在丙型肝炎慢性患者干扰素治疗过程的前8周内。在此,我们描述1例在α干扰素治疗开始4个月后发生的Vogt-小柳原田病,可能是由干扰素的免疫调节作用诱发的。因此,我们得出结论,丙型肝炎慢性患者,尤其是皮肤色素沉着较深的人,在干扰素治疗期间需要通过定期检查眼底,长期密切监测眼科并发症。

相似文献

1
Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.慢性丙型肝炎干扰素α治疗期间发生的葡萄膜炎-小柳-原田病。
J Gastroenterol. 2004 Nov;39(11):1106-9. doi: 10.1007/s00535-004-1452-4.
2
Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.与干扰素-α和利巴韦林治疗慢性丙型肝炎感染相关的葡萄膜炎-小柳-原田病
J Infect. 2006 Feb;52(2):e59-61. doi: 10.1016/j.jinf.2005.05.005. Epub 2005 Jun 13.
3
[Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].[与干扰素-α和利巴韦林治疗慢性丙型肝炎感染相关的小柳原田病]
J Fr Ophtalmol. 2010 Mar;33(3):185-8. doi: 10.1016/j.jfo.2010.01.009. Epub 2010 Feb 20.
4
Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.在干扰素-α和利巴韦林治疗慢性丙型肝炎病毒感染期间发生的葡萄膜炎-小柳-原田病
Int Ophthalmol. 2010 Oct;30(5):611-3. doi: 10.1007/s10792-010-9357-0. Epub 2010 Feb 23.
5
Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy.与干扰素α-2b/利巴韦林联合治疗相关的葡萄膜炎-小柳原田病
J Viral Hepat. 2003 Nov;10(6):467-70. doi: 10.1046/j.1365-2893.2003.00456.x.
6
Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C.慢性丙型肝炎干扰素α治疗期间的视网膜并发症与血浆C5a水平
Am J Gastroenterol. 1998 Dec;93(12):2441-4. doi: 10.1111/j.1572-0241.1998.00701.x.
7
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.聚乙二醇化干扰素-α2b与利巴韦林联合治疗慢性丙型肝炎期间发生的葡萄膜炎-小柳-原田病
Korean J Hepatol. 2011 Mar;17(1):61-5. doi: 10.3350/kjhep.2011.17.1.61.
8
Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C.慢性丙型病毒性肝炎患者接受干扰素-α和利巴韦林治疗的眼内并发症
World J Gastroenterol. 2007 Jun 14;13(22):3137-40. doi: 10.3748/wjg.v13.i22.3137.
9
Interferon-alpha2a and Vogt-Koyanagi-Harada disease: a double-edged sword?干扰素α2a与葡萄膜大脑炎:一把双刃剑?
Int Ophthalmol. 2007 Apr-Jun;27(2-3):211-5. doi: 10.1007/s10792-007-9040-2. Epub 2007 Feb 23.
10
Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.干扰素-α和利巴韦林治疗丙型肝炎诱导 Vogt-Koyanagi-Harada 病:病例报告及文献复习。
Ocul Immunol Inflamm. 2019;27(2):229-234. doi: 10.1080/09273948.2017.1373827. Epub 2017 Oct 12.

引用本文的文献

1
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature.索磷布韦/利巴韦林治疗ombitasvir/paritaprevir/ritonavir+利巴韦林治疗失败的患者:两例报告及文献复习
World J Clin Cases. 2019 May 6;7(9):1043-1052. doi: 10.12998/wjcc.v7.i9.1043.
2
Serous Retinal Detachments Complicating Interferon-α and Ribavirin Treatment in Patients with Hepatitis C.丙型肝炎患者使用α-干扰素和利巴韦林治疗并发浆液性视网膜脱离
Case Rep Ophthalmol. 2011 Jan;2(1):105-10. doi: 10.1159/000326747. Epub 2011 Mar 12.
3
Relapse of Vogt-Koyanagi-Harada Disease during Interferon-α and Ribavirin Therapy in a Case of Chronic Viral Hepatitis C.
丙型慢性病毒性肝炎患者在接受α干扰素和利巴韦林治疗期间伏格特-小柳-原田病复发
Case Rep Ophthalmol. 2011 Jan 7;2(1):5-9. doi: 10.1159/000323472.
4
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.聚乙二醇化干扰素-α2b与利巴韦林联合治疗慢性丙型肝炎期间发生的葡萄膜炎-小柳-原田病
Korean J Hepatol. 2011 Mar;17(1):61-5. doi: 10.3350/kjhep.2011.17.1.61.
5
Cystoid macular edema and visual loss as sequelae to interferon alpha treatment of systemic hepatitis C.结节性黄斑水肿和视力丧失是全身丙型肝炎干扰素 α 治疗的后遗症。
Indian J Ophthalmol. 2010 Mar-Apr;58(2):147-8. doi: 10.4103/0301-4738.60088.
6
Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.在干扰素-α和利巴韦林治疗慢性丙型肝炎病毒感染期间发生的葡萄膜炎-小柳-原田病
Int Ophthalmol. 2010 Oct;30(5):611-3. doi: 10.1007/s10792-010-9357-0. Epub 2010 Feb 23.
7
Interferon-alpha-associated presumed ocular sarcoidosis.干扰素α相关的疑似眼部结节病
Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):675-80. doi: 10.1007/s00417-008-1002-5. Epub 2008 Nov 26.
8
Interferon-alpha2a and Vogt-Koyanagi-Harada disease: a double-edged sword?干扰素α2a与葡萄膜大脑炎:一把双刃剑?
Int Ophthalmol. 2007 Apr-Jun;27(2-3):211-5. doi: 10.1007/s10792-007-9040-2. Epub 2007 Feb 23.